No registrations found.
ID
NL-OMON26400
Source
NTR
Brief title
icoPET
Health condition
peritoneal dialysis, PET test, icodextrin, preceding dwell
Sponsors and support
Primary sponsor
:
MUMC+
Source(s) of monetary or material Support
:
none
Intervention
Outcome measures
Primary outcome
D/P creatinine.
Secondary outcome
1. D/P sodium;
2. D/P urea;
3. Ultrafiltration volumes.
Background summary
Comparing the effect of 3.86% glucose versus icodextrin as preceding dwells on the results of the 3.86% glucose PET in CAPD.
Study objective
Preceding dwell with icodextrin does not influence the results of the 3.86% glucose PET in CAPD.
Study design
Two PETs within 2 weeks.
Intervention
Two Peritoneal Equilibration Tests in CAPD patients with different preceding long dwells (3.86% glucose versus icodextrin).
Public
Maastricht UMC+, Department of internal mdecine, subdivision of nephrology, P. de Debyelaan 25
T.T. Cnossen
Maastricht UMC+, Department of internal mdecine, subdivision of nephrology, P. de Debyelaan 25
Maastricht 6229, HX
The Netherlands
(+31)43.3875007
nynke.cnossen@mumc.nl
T.T. Cnossen
Maastricht UMC+, Department of internal mdecine, subdivision of nephrology, P. de Debyelaan 25
Maastricht 6229, HX
The Netherlands
(+31)43.3875007
nynke.cnossen@mumc.nl
Scientific
Maastricht UMC+, Department of internal mdecine, subdivision of nephrology, P. de Debyelaan 25
T.T. Cnossen
Maastricht UMC+, Department of internal mdecine, subdivision of nephrology, P. de Debyelaan 25
Maastricht 6229, HX
The Netherlands
(+31)43.3875007
nynke.cnossen@mumc.nl
T.T. Cnossen
Maastricht UMC+, Department of internal mdecine, subdivision of nephrology, P. de Debyelaan 25
Maastricht 6229, HX
The Netherlands
(+31)43.3875007
nynke.cnossen@mumc.nl
Inclusion criteria
1. Stable CAPD;
2. Older than 18 years;
3. Peritonitis-free at least 6 weeks before and between both PETs;
4. Able to give informent consent.
Exclusion criteria
1. Allergy to icodextrin;
2. Peritonitis less than 6 weeks before forst PET or between both PETs.
Design
Study type
:
Interventional
Intervention model
:
Crossover
Allocation
:
Randomized controlled trial
Masking
:
Open (masking not used)
Control
:
Active
Recruitment
NL
Recruitment status
:
Pending
Start date (anticipated)
:
Enrollment
:
20
Type
:
Anticipated
Positive opinion
Date
:
Application type
:
First submission
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
| Register | ID |
|---|---|
| NTR-new | NL1899 |
| NTR-old | NTR2015 |
| Other | METC Maastricht University MC : MEC 09-2-084/NL28726.068.09 |
| ISRCTN | ISRCTN wordt niet meer aangevraagd. |
Summary results
TT Cnossen, CH Beerenhout, CJAM Konings, JP Kooman, KM Leunissen, W Smit, RT Krediet. Influence of the preceding dwell time on the peritoneal equilibration test with 3.86% glucose in automated peritoneal dialysis. Perit Dial Int 2009;29 (accepted).<br>
2009 TT Cnossen, W Smit, CJAM Konings, JP Kooman, KM Leunissen, RT Krediet. Quantification of free water transport during the peritoneal equilibration test. Perit Dial Int 2009;29 (accepted).<br>
2008 R van den Berg, TT Cnossen, CJAM Konings, JP Kooman, FM van der Sande, KML Leunissen. Different treatment options in peritoneal dialysis. NDT Plus 2008;1(4):14-7.<br>
2008 TT Cnossen, JP Kooman, FM van der Sande, CJAM Konings, KML Leunissen. Clinical effects of icodextrin in peritoneal dialysis. NDT Plus 2008;1(4):18-22.
2008 Van Leusen R, Adang RP, de Vries RA, Cnossen TT, Konings CJ, Schalm SW, Tan AC. Pegylated Interferon Alfa-2a (40 kD) and Ribavirin in Haemodialysis Patients with Chronic Hepatitis C. Nephrol Dial Transplant 2008 Feb;23(2):721-5.<br>
2006 JP Kooman, N Cnossen, CJ Konings, FM van der Sande, KM Leunissen. Is there a competition between urine volume and peritoneal ultrafiltration in peritoneal dialysis patients? Contrib Nephrol 2006;150:111-8.
2006 N Cnossen, JP Kooman, CJ Konings, JM van Dantzig, FM van der Sande, K Leunissen. Peritoneal dialysis in patients with congestive heart failure. Nephrol Dial Transplant 2006 Jul;21(2):63-6.<br>
2006 TT Cnossen, CJAM Konings, JP Kooman, B Lindholm. How to prevent peritoneal sclerosis -- aetiology, diagnosis, treatment and prevention. Nephrol Dial Transplant 2006 Jul;21(2):38-41.<br>
2003 GJ Boland, N Cnossen, T van Bommel, A Rulos - van den Berg, JP van den Berg, AM van Loon, J van Hattum. Molecular diversity of hepatitis C in the Batam region. Adv Exp Med Biol 2003;531:211-7.
2009 TT Cnossen, W Smit, CJAM Konings, JP Kooman, KM Leunissen, RT Krediet. Quantification of free water transport during the peritoneal equilibration test. Perit Dial Int 2009;29 (accepted).<br>
2008 R van den Berg, TT Cnossen, CJAM Konings, JP Kooman, FM van der Sande, KML Leunissen. Different treatment options in peritoneal dialysis. NDT Plus 2008;1(4):14-7.<br>
2008 TT Cnossen, JP Kooman, FM van der Sande, CJAM Konings, KML Leunissen. Clinical effects of icodextrin in peritoneal dialysis. NDT Plus 2008;1(4):18-22.
2008 Van Leusen R, Adang RP, de Vries RA, Cnossen TT, Konings CJ, Schalm SW, Tan AC. Pegylated Interferon Alfa-2a (40 kD) and Ribavirin in Haemodialysis Patients with Chronic Hepatitis C. Nephrol Dial Transplant 2008 Feb;23(2):721-5.<br>
2006 JP Kooman, N Cnossen, CJ Konings, FM van der Sande, KM Leunissen. Is there a competition between urine volume and peritoneal ultrafiltration in peritoneal dialysis patients? Contrib Nephrol 2006;150:111-8.
2006 N Cnossen, JP Kooman, CJ Konings, JM van Dantzig, FM van der Sande, K Leunissen. Peritoneal dialysis in patients with congestive heart failure. Nephrol Dial Transplant 2006 Jul;21(2):63-6.<br>
2006 TT Cnossen, CJAM Konings, JP Kooman, B Lindholm. How to prevent peritoneal sclerosis -- aetiology, diagnosis, treatment and prevention. Nephrol Dial Transplant 2006 Jul;21(2):38-41.<br>
2003 GJ Boland, N Cnossen, T van Bommel, A Rulos - van den Berg, JP van den Berg, AM van Loon, J van Hattum. Molecular diversity of hepatitis C in the Batam region. Adv Exp Med Biol 2003;531:211-7.